The stock of Faron Pharmaceuticals Oy (LON:FARN) is a huge mover today! The stock closed at GBX 252 during the last session. It is up 2.14% since April 19, 2016 and is downtrending. It has underperformed by 6.57% the S&P500.
The move comes after 7 months negative chart setup for the GBX 64.04 million company. It was reported on Nov, 18 by Barchart.com. We have GBX 221.76 PT which if reached, will make LON:FARN worth GBX 7.68M less.
Faron Pharmaceuticals Oy (LON:FARN) Ratings Coverage
Out of 2 analysts covering Faron Pharmaceuticals Oy Ord Npv Di (LON:FARN), 2 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Faron Pharmaceuticals Oy Ord Npv Di has been the topic of 7 analyst reports since January 4, 2016 according to StockzIntelligence Inc. As per Wednesday, June 15, the company rating was maintained by Panmure Gordon. Panmure Gordon maintained it with “Buy” rating and GBX 361 target price in Monday, October 24 report. On Monday, July 25 the stock rating was maintained by Panmure Gordon with “Buy”. The rating was maintained by Panmure Gordon with “Buy” on Wednesday, August 24. The stock has “Buy” rating given by Panmure Gordon on Monday, September 5. As per Monday, October 31, the company rating was maintained by Panmure Gordon.
Faron Pharmaceuticals Oy is a Finland biopharmaceutical firm engaged in the biotechnology and medical research industry. The company has a market cap of 64.04 million GBP. The Firm develops late stage clinical drugs focusing on acute organ traumas, cancer immunotherapy and vascular damage. It currently has negative earnings.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.